Home Reported Outcomes in C3G Study
NCT07029542
·
clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
C3 Glomerulopathy
Sponsor
Novartis Pharmaceuticals